PoLoPo has won the Coller startup competition FoodTech track, which took place in July 2022, thus securing its first investment from CPT Capital. The co-founders met over 15 years ago, during their PhD studies at the Hebrew University of Jerusalem and worked side by side for 6 years. Raya Liberman-Aloni are plant metabolic engineers, experts in expression and targeting of functional proteins in plants. “We’ve been very impressed by the disruptive potential of their platform technology and, most importantly, by the deep plant science expertise of PoLoPo's founders and their bold vision for the company”, said Christian Guba, “We believe they are set to complement the incumbents in Precision Fermentation by pioneering a simpler approach to develop proteins.” PoLoPo’s potato-to-protein pathway commercial scalability since plants require relatively low investment to grow and are amenable to upscaling by common agricultural practice. Produced in over 100 countries worldwide and the third most important food crop in the world, potatoes are an abundant, resilient, cheap, and versatile yet underused food source. Molecular farming technology, being harnessed for the production of high-quality proteins, presents a huge opportunity to do so, alongside with taking the animals out of the equation and reducing the carbon footprint of the production process” said Dr. “We want to produce better food for the world. “With this substantial funding we are aiming to reach several significant milestones including protein rich potato tubers and Ovalbumin functional samples.” “We’re glad to have won a group of such renowned and like-minded investors”, said Dr. PoLoPo’s Ovalbumin will be identical to “real” egg Ovalbumin in terms of functionality, nutritional value, and protein sequence. The company is building a technology platform for protein production, starting out with Ovalbumin (protein of the egg white), targeting the $26.6 billion egg protein market as well as the growing demand for egg white protein alternatives from the industry. PoLoPo has developed a proprietary technology to express proteins in potatoes in a scalable, cost-effective way, in order to meet the food industries’ protein demands and to nourish the world’s growing population. With the fresh funding, PoLoPo will further expand its core team of world-class scientists and accelerate their R&D efforts in order to offer prototypes in the coming year and a half. The Pre-seed round was led by FoodLabs, further investors include CPT Capital, Siddhi Capital, Plug and Play Ventures, Milk & Honey Ventures and HackCapital. Rehovot, : Israeli molecular farming company PoLoPo has closed a $1.75m funding round to double down on developing its proprietary technology to grow animal proteins in potatoes - the world’s most widely grown non-cereal food crop. Leveraging a cost-effective protein source to meet the food industry’s protein demands and to nourish the world’s growing population PoLoPo to further develop its proprietary technology to grow egg proteins in potatoes: a plant biofactory producing proteins that can be used as functional ingredients in the food industry Molecular Farming startup PoLoPo secures $1.75m Pre-seed round to double down on its unique approach for animal-based proteins, growing in plantsįunding round led by FoodLabs, further investors include CPT Capital, Siddhi Capital, Plug and Play Ventures, Milk & Honey Ventures and HackCapital
0 Comments
Leave a Reply. |